Transitions

Transitions Magazine

Transitions is published bi-monthly for members of the APhA New Practitioner Network. The online newsletter contains information focused on life inside and outside pharmacy practice, providing guidance on various areas of professional, personal, and practice development. Each issue includes in-depth articles on such topics as personal financial management, innovative practice sites, career profiles, career development tools, residency and postgraduate programs, and more.

FDA warns of dental problems associated with certain buprenorphine...

Tuesday, January 18, 2022 0 27161

FDA is drawing attention to dental problems linked to buprenorphine-containing medications that are dissolved under the tongue or placed against the inside of the cheek to treat opioid use disorder and pain.

ISMP issues warning about possible safety issues with newly authorized...

Tuesday, January 11, 2022 0 27006

To encourage the appropriate use of Pfizer’s COVID-19 antiviral drug nirmatrelvir/ritonavir (Paxlovid), the Institute for Safe Medication Practices (ISMP) released an alert for dispensing pharmacists.

Study links statins with more aggressive diabetes progression

Patients with diabetes who used statins experienced less control of their diabetes than patients who did not take statins, suggests a new...

FDA puts clozapine REMS requirements on temporary hold

FDA said it is temporarily halting its risk evaluation and mitigation strategy (REMS) program for clozapine, a treatment for schizophrenia.

Update on biosimilars: Recent approvals, role for pharmacists

This year has seen the approval of 2 new biosimilar drugs, including the first biosimilar to earn FDA’s “interchangeable”...

In case you missed it: new study warns against acetaminophen use during...

A recent study published in Nature Reviews Endocrinology sheds light on the debate about acetaminophen use for pregnant women. After reviewing the...

New impurities lurking in some heart medications

Over the past few years, blood pressure medications have been recalled due to concerns about N-nitrosodimethylamine (NDMA), a probable carcinogen....

FDA takes steps to improve quality, safety of sunscreens

FDA is working to improve the quality, safety, and efficacy of sunscreens as part of its implementation of new authorities for certain OTC drugs.

Tuesday, September 14, 2021

Federal government makes two announcements with major pharmacy implications in 24 hours

September 9, 2021, was a busy day for the federal government and pharmacy stakeholders alike: Just a few hours apart, we saw significant developments in pharmacists’ COVID-19 pandemic practice authorities and prescription drug pricing. Both items yielded positive news for pharmacists and their patients.

Tuesday, September 7, 2021

Tocilizumab in short supply due to pandemic

Some individuals with rheumatoid arthritis (RA) are treated with a monthly infusion of the biologic tocilizumab (Actemra—Genentech). However, the drug is now in short supply because of the surge in COVID-19 cases.

1 2

Transitions Magazine

FDA warns of dental problems associated with certain buprenorphine...

ISMP issues warning about possible safety issues with newly authorized...

Study links statins with more aggressive diabetes progression

FDA puts clozapine REMS requirements on temporary hold

Update on biosimilars: Recent approvals, role for pharmacists

In case you missed it: new study warns against acetaminophen use during...

New impurities lurking in some heart medications

FDA takes steps to improve quality, safety of sunscreens

Federal government makes two announcements with major pharmacy implications in 24 hours

Tocilizumab in short supply due to pandemic